v3.26.1
STOCKHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option Activity
A summary of stock option activity for the six months ended June 30, 2026 is as follows:
Number of Shares (in thousands)Weighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 20252,262 $33.78 1.8$4,420 
Exercised(427)20.47 
Canceled(3)19.55 
Outstanding at June 30, 20261,832 $36.90 1.7$— 
Options vested and exercisable at June 30, 20261,832 $36.90 1.7$— 
Schedule of RSU Activity A summary of RSU and PRSU activity for the six months ended June 30, 2026 is as follows (in thousands, except per share amounts):
Number of SharesWeighted-Average Grant Date Fair Value
Nonvested at December 31, 20254,898 $38.72 
Granted3,997 28.65 
Vested(1)
(1,946)34.74 
Canceled(575)36.47 
Nonvested at June 30, 2026(2)
6,374 $33.82 
Expected to vest at June 30, 2026(2)
6,347 $33.86 
(1)    Includes approximately 0.8 million shares that vested but were not issued due to the Company’s use of net share settlement for payment of employee taxes.
(2)    Includes approximately 0.8 million PRSUs.
Schedule of Stock-Based Compensation Expense
The following table summarizes the effects of stock-based compensation expense related to stock-based awards in the condensed consolidated statements of operations during the periods presented (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Cost of revenue$1,242 $1,070 $2,382 $2,241 
Sales and marketing6,082 7,295 12,536 14,934 
Product development10,671 17,846 25,381 37,255 
General and administrative7,754 8,564 15,957 17,814 
Total stock-based compensation recorded to income before income taxes25,749 34,775 56,256 72,244 
Benefit from income taxes(5,434)(7,008)(11,398)(14,419)
Total stock-based compensation recorded to net income attributable to common stockholders$20,315 $27,767 $44,858 $57,825